Oxford BioMedica News
Most Popular Oxford BioMedica Story
Oxford BioMedica surges on Parkinson's trial success
Following hot on the heels of Phytopharm's announcement yesterday that its Parkinson's treatment had delivered promising results in animal and human studies, Oxford BioMedica thrilled analysts with a Read more...
Latest Headlines
- October 15, 2009
- September 22, 2009
- July 6, 2009
- April 29, 2009
- October 7, 2008
- September 4, 2008
- August 15, 2008
- March 26, 2008
- March 12, 2008
- February 12, 2008
- February 11, 2008
- January 10, 2008
- September 11, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
